catechin has been researched along with Bladder Pain Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awwad, J; Bazi, T; Hajj-Hussein, IA; Hijaz, M; Jurjus, A; Shams, A | 1 |
| Che, JP; Feng, Y; Liu, M; Luo, J; Wang, GC; Xu, YF; Yang, FQ; Zhai, W; Zheng, JH | 1 |
1 trial(s) available for catechin and Bladder Pain Syndrome
| Article | Year |
|---|---|
Epigallocatechin gallate attenuates interstitial cystitis in human bladder urothelium cells by modulating purinergic receptors.
Topics: Adenosine Triphosphate; Antioxidants; Case-Control Studies; Catechin; Cells, Cultured; Cystitis, Interstitial; Epithelial Cells; Female; Humans; Nitric Oxide Synthase Type II; Receptors, Purinergic; Urothelium | 2013 |
1 other study(ies) available for catechin and Bladder Pain Syndrome
| Article | Year |
|---|---|
A modulating effect of epigallocatechin gallate (EGCG), a tea catechin, on the bladder of rats exposed to water avoidance stress.
Topics: Animals; Catechin; Cell Degranulation; Cystitis, Interstitial; Defecation; Disease Models, Animal; Female; Immersion; Injections, Intraperitoneal; Mast Cells; Rats; Rats, Sprague-Dawley; Stress, Psychological; Time Factors; Urinary Bladder; Urination; Water | 2013 |